ORANGE COUNTY, Calif., Oct.
, one of the largest and most experienced cultivators, manufacturers, and distributors of cannabis in the U.S., will be the brand’s national cultivation and manufacturing partner in the markets where the Company operates.
We are grateful for the trust and confidence Mike has given our vast industry experience,” said Jesse Channon, Columbia Care’s Chief Growth Officer.
“Cannabis has changed me for the good both mentally and physically, and I want to share that gift with others who are also seeking relief.
Tyson 2.0 will be led by Adam Wilks, who brings with him significant experience in cannabis operations and retail licensing.
Tyson and Bronstein were introduced by Azim Spicer, Tyson 2.0’s Head of Business Development, when Tyson made an investment in his psychedelic healthcare company, Wesana.
The Tyson brand combined with a major cultivation partner like Columbia Care, with their trusted and proven reputation in the industry, will ensure that consumers have access to the cannabis strains and form factors that Mike believes in,” said Bronstein.
Tyson 2.0 has completed a seed round led by Sol Global, K2, Ambria, and Arcadian Capital.
“We get what makes a cannabis venture highly successful and Tyson 2.0 now has all the right elements in place,” said Andrew DeFrancesco, CEO and Chairman of Sol Global.
Providing consumers an outstanding selection of products, Tyson 2.0 is an extraordinary balance of premium and affordable, full-spectrum cannabis flower, concentrates, and consumables available at retailers nationwide.
In 2021, the company launched Cannabist, its new retail brand, creating a national dispensary network that leverages proprietary technology platforms. The company offers products spanning flower, edibles, oils and tablets, and manufactures popular brands including Seed & Strain, Triple Seven, gLeaf, Classix, Press, Amber and Platinum Label CBD.
The above press release was provided courtesy of PRNewswire.